Accessory molecules for Toll-like receptors and their function (original) (raw)
Janeway, C. A. Jr & Medzhitov, R. Introduction: the role of innate immunity in the adaptive immune response. Semin. Immunol.10, 349–350 (1998). ArticlePubMed Google Scholar
Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol.81, 1–5 (2007). ArticleCASPubMed Google Scholar
Kang, J. Y. & Lee, J.-O. Structural biology of the Toll-like receptor family. Annu. Rev. Biochem.80, 917–941 (2011). ArticleCASPubMed Google Scholar
Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol.11, 373–384 (2010). ArticleCAS Google Scholar
O'Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev. Immunol.7, 353–364 (2007). CAS Google Scholar
Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nature Rev. Immunol.7, 179–190 (2007). CAS Google Scholar
Liew, F. Y., Xu, D., Brint, E. K. & O'Neill, L. A. Negative regulation of Toll-like receptor-mediated immune responses. Nature Rev. Immunol.5, 446–458 (2005). ArticleCAS Google Scholar
Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nature Rev. Immunol.10, 210–215 (2010). ArticleCAS Google Scholar
Ulevitch, R. J. & Tobias, P. S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol.13, 437–457 (1995). ArticleCASPubMed Google Scholar
Jiang, Z. et al. CD14 is required for MyD88-independent LPS signaling. Nature Immunol.6, 565–570 (2005). ArticleCAS Google Scholar
Dziarski, R., Tapping, R. I. & Tobias, P. S. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem.273, 8680–8690 (1998). ArticleCASPubMed Google Scholar
Schroder, N. W. et al. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol.173, 2683–2691 (2004). ArticlePubMed Google Scholar
Schroder, N. W. et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem.278, 15587–15594 (2003). ArticlePubMed Google Scholar
Jack, R. S. et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature389, 742–745 (1997). ArticleCASPubMed Google Scholar
Weber, J. R. et al. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity19, 269–279 (2003). ArticleCASPubMed Google Scholar
Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med.189, 1777–1782 (1999). ArticleCASPubMedPubMed Central Google Scholar
Nagai, Y. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nature Immunol.3, 667–672 (2002). ArticleCAS Google Scholar
Park, B. S. et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature458, 1191–1195 (2009). This paper is the first description of the crystal structure of a TLR in complex with its ligand and an accessory molecule. ArticleCASPubMed Google Scholar
Calvo, D., Dopazo, J. & Vega, M. A. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Genomics25, 100–106 (1995). ArticleCASPubMed Google Scholar
Triantafilou, M. et al. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem.281, 31002–31011 (2006). ArticleCASPubMed Google Scholar
Stuart, L. M. et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol.170, 477–485 (2005). ArticleCASPubMedPubMed Central Google Scholar
Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol.11, 155–161 (2010). ArticleCAS Google Scholar
Tao, N., Wagner, S. J. & Lublin, D. M. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J. Biol. Chem.271, 22315–22320 (1996). ArticleCASPubMed Google Scholar
Hailman, E. et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med.179, 269–277 (1994). ArticleCASPubMed Google Scholar
Lee, H. K., Dunzendorfer, S., Soldau, K. & Tobias, P. S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity24, 153–163 (2006). This paper provided the first concrete evidence that CD14 is important for endosomal TLRs in addition to surface TLRs. ArticleCASPubMed Google Scholar
Nakata, T. et al. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol.8, 1899–1909 (2006). ArticleCASPubMed Google Scholar
Kim, J. I. et al. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem.280, 11347–11351 (2005). ArticleCASPubMed Google Scholar
Haziot, A. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity4, 407–414 (1996). ArticleCASPubMed Google Scholar
Zanoni, I. et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell147, 868–880 (2011). This was the first description of LPS-induced trafficking of TLR4 by CD14. ArticleCASPubMedPubMed Central Google Scholar
Akashi-Takamura, S. & Miyake, K. TLR accessory molecules. Curr. Opin. Immunol.20, 420–425 (2008). ArticleCASPubMed Google Scholar
da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S. & Ulevitch, R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem.276, 21129–21135 (2001). ArticleCASPubMed Google Scholar
Gioannini, T. L. et al. Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl Acad. Sci. USA101, 4186–4191 (2004). ArticleCASPubMedPubMed Central Google Scholar
Compton, T. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol.77, 4588–4596 (2003). ArticleCASPubMedPubMed Central Google Scholar
Georgel, P. et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology362, 304–313 (2007). ArticleCASPubMed Google Scholar
Kurt-Jones, E. A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol.1, 398–401 (2000). ArticleCAS Google Scholar
Carpenter, S. et al. TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain. J. Immunol.183, 3989–3995 (2009). ArticleCASPubMed Google Scholar
Carpenter, S., Wochal, P., Dunne, A. & O'Neill, L. A. Toll-like receptor 3 (TLR3) signaling requires TLR4 interactor with leucine-rich repeats (TRIL). J. Biol. Chem.286, 38795–38804 (2011). ArticleCASPubMedPubMed Central Google Scholar
Kessenbrock, K. et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J. Clin. Invest.118, 2438–2447 (2008). CASPubMedPubMed Central Google Scholar
Zhu, J. et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell111, 867–878 (2002). ArticleCASPubMed Google Scholar
Park, B. et al. Granulin is a soluble cofactor for Toll-like receptor 9 signaling. Immunity34, 505–513 (2011). Here, granulin was shown to have an essential role in ligand delivery for TLR9 activation. ArticlePubMedCAS Google Scholar
Lotze, M. T. & Tracey, K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Rev. Immunol.5, 331–342 (2005). ArticleCAS Google Scholar
Andersson, U. & Tracey, K. J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol.29, 139–162 (2011). ArticleCASPubMedPubMed Central Google Scholar
Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunol.8, 487–496 (2007). This work first reported a role for HMGB1 in delivering DNA to TLR9. ArticleCAS Google Scholar
Urbonaviciute, V. et al. Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med.205, 3007–3018 (2008). ArticleCASPubMedPubMed Central Google Scholar
Leadbetter, E. A. et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature416, 603–607 (2002). ArticleCASPubMed Google Scholar
Avalos, A. M. et al. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autoimmunity43, 103–110 (2010). ArticleCASPubMedPubMed Central Google Scholar
Yanai, H. et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature462, 99–103 (2009). ArticleCASPubMed Google Scholar
Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature449, 564–569 (2007). This paper demonstrated the role of LL37 in DNA delivery to TLR9 in pDCs. ArticleCASPubMed Google Scholar
Gilliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol.20, 401–407 (2008). CASPubMed Google Scholar
Zanetti, M., Gennaro, R. & Romeo, D. The cathelicidin family of antimicrobial peptide precursors: a component of the oxygen-independent defense mechanisms of neutrophils. Ann. NY Acad. Sci.832, 147–162 (1997). ArticleCASPubMed Google Scholar
Ganguly, D. et al. Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med.206, 1983–1994 (2009). ArticleCASPubMedPubMed Central Google Scholar
Yang, Y. & Li, Z. Roles of heat shock protein gp96 in the ER quality control: redundant or unique function? Mol. Cells20, 173–182 (2005). ArticleCASPubMed Google Scholar
Liu, B. & Li, Z. Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin. Blood112, 1223–1230 (2008). ArticleCASPubMedPubMed Central Google Scholar
Randow, F. & Seed, B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nature Cell Biol.3, 891–896 (2001). ArticleCASPubMed Google Scholar
Wanderling, S. et al. GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion. Mol. Biol. Cell18, 3764–3775 (2007). ArticleCASPubMedPubMed Central Google Scholar
Yang, Y. et al. Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity26, 215–226 (2007). ArticlePubMedPubMed CentralCAS Google Scholar
Staron, M. et al. Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex. Blood117, 7136–7144 (2011). ArticleCASPubMedPubMed Central Google Scholar
Liu, B. et al. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nature Commun.1, 79 (2010). This paper shows that GRP94 and PRAT4A work together to chaperone TLRs. ArticleCAS Google Scholar
Wakabayashi, Y. et al. A protein associated with Toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J. Immunol.177, 1772–1779 (2006). ArticleCASPubMed Google Scholar
Takahashi, K. et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J. Exp. Med.204, 2963–2976 (2007). ArticleCASPubMedPubMed Central Google Scholar
Kiyokawa, T. et al. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors. Int. Immunol.20, 1407–1415 (2008). ArticleCASPubMed Google Scholar
Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nature Immunol.7, 156–164 (2006). ArticleCAS Google Scholar
Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science314, 308–312 (2006). ArticleCASPubMed Google Scholar
Brinkmann, M. M. et al. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol.177, 265–275 (2007). ArticleCASPubMedPubMed Central Google Scholar
Kim, Y. M., Brinkmann, M. M., Paquet, M. E. & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature452, 234–238 (2008). This paper provides evidence for the role of UNC93B1 in the trafficking of endosomal TLRs. ArticleCASPubMed Google Scholar
Fukui, R. et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J. Exp. Med.206, 1339–1350 (2009). ArticleCASPubMedPubMed Central Google Scholar
Fukui, R. et al. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity35, 69–81 (2011). ArticleCASPubMed Google Scholar
Nakatsu, F. & Ohno, H. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct. Funct.28, 419–429 (2003). ArticleCASPubMed Google Scholar
Sasai, M., Linehan, M. M. & Iwasaki, A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science329, 1530–1534 (2010). This study was the first to demonstrate that AP3 has a role in TLR9-dependent IFN responses. ArticleCASPubMedPubMed Central Google Scholar
Blasius, A. L. et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA107, 19973–19978 (2010). ArticleCASPubMedPubMed Central Google Scholar
Guiducci, C. et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med.203, 1999–2008 (2006). ArticleCASPubMedPubMed Central Google Scholar
Honda, K. et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction. Nature434, 1035–1040 (2005). ArticleCASPubMed Google Scholar
Park, B. et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nature Immunol.9, 1407–1414 (2008). References 79 and 80 demonstrate the cleavage requirement for TLR9 activation by CpG DNA. ArticleCAS Google Scholar
Asagiri, M. et al. Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science319, 624–627 (2008). ArticleCASPubMed Google Scholar
Matsumoto, F. et al. Cathepsins are required for Toll-like receptor 9 responses. Biochem. Biophys. Res. Commun.367, 693–699 (2008). ArticleCASPubMed Google Scholar
Sepulveda, F. E. et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity31, 737–748 (2009). This is the first demonstration of a role for AEP in TLR9 activation in primary DCs. ArticleCASPubMed Google Scholar
Ewald, S. E. et al. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J. Exp. Med.208, 643–651 (2011). ArticleCASPubMedPubMed Central Google Scholar
Saitoh, T. et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity34, 352–363 (2011). ArticleCASPubMed Google Scholar
Gerold, G. et al. A Toll-like receptor 2–integrin β3 complex senses bacterial lipopeptides via vitronectin. Nature Immunol.9, 761–768 (2008). ArticleCAS Google Scholar
Kagan, J. C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell125, 943–955 (2006). ArticleCASPubMed Google Scholar
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. & Underhill, D. M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med.197, 1107–1117 (2003). ArticleCASPubMedPubMed Central Google Scholar
Nagai, Y. et al. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes. J. Immunol.174, 7043–7049 (2005). ArticleCASPubMed Google Scholar
Divanovic, S. et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nature Immunol.6, 571–578 (2005). ArticleCAS Google Scholar
Blumenthal, A. et al. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe5, 35–46 (2009). ArticleCASPubMedPubMed Central Google Scholar
Uccellini, M. B. et al. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-α. J. Immunol.181, 5875–5884 (2008). ArticleCASPubMed Google Scholar
Viglianti, G. A. et al. Activation of autoreactive B cells by CpG dsDNA. Immunity19, 837–847 (2003). ArticleCASPubMed Google Scholar
Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med.202, 1171–1177 (2005). ArticleCASPubMedPubMed Central Google Scholar
Chaturvedi, A., Dorward, D. & Pierce, S. K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity28, 799–809 (2008). ArticleCASPubMedPubMed Central Google Scholar
Avalos, A. M. et al. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides. J. Immunol.183, 6262–6268 (2009). ArticleCASPubMed Google Scholar
Hori, O. et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem.270, 25752–25761 (1995). ArticleCASPubMed Google Scholar
Bierhaus, A. et al. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med.83, 876–886 (2005). ArticleCASPubMed Google Scholar
Boullier, A. et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem.275, 9163–9169 (2000). ArticleCASPubMed Google Scholar
Coraci, I. S. et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol.160, 101–112 (2002). ArticleCASPubMedPubMed Central Google Scholar
Jimenez-Dalmaroni, M. J. et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE4, e7411 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Yang, R. B., Mark, M. R., Gurney, A. L. & Godowski, P. J. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol.163, 639–643 (1999). CASPubMed Google Scholar
Muta, T. & Takeshige, K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of Toll-like receptor (TLR)2 as well as TLR4 reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur. J. Biochem.268, 4580–4589 (2001). ArticleCASPubMed Google Scholar